86 related articles for article (PubMed ID: 3087307)
1. Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.
Moore RD; Smith CR; Holloway JJ; Lietman PS
Arch Intern Med; 1986 Jun; 146(6):1153-7. PubMed ID: 3087307
[TBL] [Abstract][Full Text] [Related]
2. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial.
Smith CR; Ambinder R; Lipsky JJ; Petty BG; Israel E; Levitt R; Mellits ED; Rocco L; Longstreth J; Lietman PS
Ann Intern Med; 1984 Oct; 101(4):469-77. PubMed ID: 6089633
[TBL] [Abstract][Full Text] [Related]
3. Cefotaxime and nafcillin-tobramycin.
Berk SL
Ann Intern Med; 1985 Feb; 102(2):275-6. PubMed ID: 3966772
[No Abstract] [Full Text] [Related]
4. Prospective double-blind controlled clinical study of sisomicin versus tobramycin.
Schieker KR; Hofmann HF
Pharmatherapeutica; 1981; 2(8):499-503. PubMed ID: 7019928
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
Jansen W; Schwarz A
Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides.
Moore RD; Smith CR; Lietman PS
Am J Med; 1986 Jun; 80(6):1093-7. PubMed ID: 3728506
[TBL] [Abstract][Full Text] [Related]
7. Effect of frequency of administration on therapeutic efficacy of cefotaxime.
Parker RH
Clin Ther; 1984; 6(4):488-99. PubMed ID: 6088045
[TBL] [Abstract][Full Text] [Related]
8. Comparative cost effectiveness of gentamicin and tobramycin.
Holloway JJ; Smith CR; Moore RD; Feroli ER; Lietman PS
Ann Intern Med; 1984 Dec; 101(6):764-9. PubMed ID: 6437310
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics in infections of the biliary tract.
Muller EL; Pitt HA; Thompson JE; Doty JE; Mann LL; Manchester B
Surg Gynecol Obstet; 1987 Oct; 165(4):285-92. PubMed ID: 3310282
[TBL] [Abstract][Full Text] [Related]
10. Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.
Parish LC; Asper R
Am J Med; 1987 Apr; 82(4A):227-9. PubMed ID: 3555041
[TBL] [Abstract][Full Text] [Related]
11. Tobramycin and gentamicin are equally safe for neonates: results of a double-blind randomized trial with quantitative assessment of renal function.
Itsarayoungyuen S; Riff L; Schauf V; Hamilton L; Otrembiak J; Vidyasagar D
Pediatr Pharmacol (New York); 1982; 2(2):143-55. PubMed ID: 12760406
[TBL] [Abstract][Full Text] [Related]
12. Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.
Weippl G
Clin Ther; 1983; 5(4):342-7. PubMed ID: 6347380
[TBL] [Abstract][Full Text] [Related]
13. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
Joshi M; Fitzpatrick BJ; Warren JW; Caplan ES; Tenney JH
Am Surg; 1986 Sep; 52(9):467-71. PubMed ID: 3530075
[TBL] [Abstract][Full Text] [Related]
15. [Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].
Martínez Jabaloyas JM; Sanz Chinesta S; Jiménez Cruz JF; Flores Corral N; Unda Urzaiz M; Leiva Galvis O; González Romojaro V; Hernández Fernández C; Lledó García E; Rioja Sanz LA; Gonzalvo Ibarra A; Camacho González JE; Ruíz Alvárez-Cienfuegos F; Resel Estévez L; Corral Saleta J; Burgos Rodríguez R; Del Rosal Samaniego JM
Actas Urol Esp; 1997; 21(7):668-74. PubMed ID: 9412209
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia].
Arich C; Gouby A; Bengler C; Ardilouze JL; Dubois A; Joubert P; Hansel S; Janbon C; Fabre S
Pathol Biol (Paris); 1987 May; 35(5):613-5. PubMed ID: 3302868
[TBL] [Abstract][Full Text] [Related]
17. Cost comparison of two antimicrobial regimens for treating mixed aerobic-anaerobic infections.
Scheife RT; Tally FP; McGowan K; Gorbach SL
Am J Hosp Pharm; 1981 Oct; 38(10):1466-9. PubMed ID: 7294038
[TBL] [Abstract][Full Text] [Related]
18. [Effect of flash chemoprophylaxis by cefotaxime on the appearance of postoperative bacterial superinfections in surgery of the prostate].
Joly-Guillou ML; Prokocimer P; Desmonts JM; Lemoine JF; Manuel C; Bergogne-Berezin E
Pathol Biol (Paris); 1985 May; 33(5):325-9. PubMed ID: 3897961
[TBL] [Abstract][Full Text] [Related]
19. A multiple-center comparative study of the kidney tolerance of ceftazidime versus cefotaxime and tobramycin.
Mondorf A; Mondorf W; Banzer S
Chemioterapia; 1987 Jun; 6(2 Suppl):331-2. PubMed ID: 2908241
[No Abstract] [Full Text] [Related]
20. Lack of evidence for interaction between tobramycin and shock in their effect on renal function.
Ambinder RF; Moore RD; Smith CR; Mellits ED; Lietman PS
Antimicrob Agents Chemother; 1985 Feb; 27(2):217-9. PubMed ID: 3885850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
